VIVEK ABHYANKAR, MD
Hematology & Oncology Physician · MARIETTA, OH
Individual Active NPI 1083607089
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 789 | 258,690 | $33,704,620 | $6,459,230 | $5,138,435 |
| 2023 | 506 | 221,924 | $25,823,346 | $4,725,493 | $3,755,950 |
| 2022 | 462 | 140,897 | $14,318,759 | $2,396,173 | $1,903,821 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 38,240 | $3 | $2 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 28,700 | $27 | $22 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19,052 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 12,602 | $55 | $44 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,950 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 8,984 | $0 | $0 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 5,800 | $45 | $36 |
| J0897 | Injection, denosumab, 1 mg | 5,460 | $26 | $21 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 4,500 | $20 | $16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,332 | $0 | $0 |
| J9030 | Bcg live intravesical instillation, 1 mg | 2,077 | $3 | $2 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,000 | $18 | $15 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 35.076795 | OH |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Ohio
- NPI 1194829721
- NPI 1477179950
- NPI 1275849788
- NPI 1376715284
- NPI 1922254937
- NPI 1134712896
- NPI 1861682916
- NPI 1659789634
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.